Bayley, Brian Eric

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 26% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bayley, Brian Eric's trades of NervGen Pharma Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
303.53
Quantity 25,464 -26.2%
Value US$835,501
Transaction date
Sale
Price
134.85
Quantity 39,122 +26.3%
Value CA$760,062
Transaction date
Sale
Price
378.93
Quantity 41,421
Value CA$1,613,686
Transaction date
Purchase
Price
0.15
Quantity 1,000
Value CA$150
Transaction date
Sale
Price
0.02
Quantity 600,000 -49.0%
Value CA$9,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-20 2025-11-19
B Purchase
25,464 -26.2%
303.53
US$835,501 		25,464 -26.2% 303.53 US$835,501
2024-03-12 2024-03-11
S Sale
39,122 +26.3%
134.85
CA$760,062 		39,122 +26.3% 134.85 CA$760,062
2023-12-05 2023-12-04
S Sale
41,421
378.93
CA$1,613,686 		41,421 378.93 CA$1,613,686
2023-12-05 2023-12-04
B Purchase
1,000
0.15
CA$150 		1,000 0.15 CA$150
2022-06-27 2022-06-27
S Sale
600,000 -49.0%
0.02
CA$9,000 		600,000 -49.0% 0.02 CA$9,000